Chauhan Jyoti 4
4 · Landos Biopharma, Inc. · Filed Nov 18, 2021
Insider Transaction Report
Form 4
Chauhan Jyoti
ED, Global Clinical Operations
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-07-26−118,054→ 155,681 totalExercise: $1.86Exp: 2030-10-19→ Common Stock (118,054 underlying) - Exercise/Conversion
Common Stock
2021-07-26$1.86/sh+118,054$219,580→ 209,299 total
Footnotes (1)
- [F1]91,245 shares of common stock underlying this option vested and became exercisable on January 1, 2021 and the remaining 182,490 shares of common stock underlying this option vest and become exercisable thereafter in 24 equal monthly installments, subject to the Reporting Person's continuous service with the Issuer on each such date.